John Televantos
Partner Arsenal Capital Partners

John Televantos is a Partner at Arsenal Capital Partners, a middle market private equity firm focused in the Specialty Industrial and Healthcare sectors. Before joining Arsenal in 2006, Dr. Televantos was President of Aqualon Company, part of Hercules, Inc.; President and Founder of Helios Chemical Company; and Chief Executive Officer for Foamex International.

John began his career with Union Carbide in 1977 in silicones research. He moved through a variety of management positions there and later at ARCO Chemical, where he became vice president of strategy and development.

At Arsenal Capital, Dr. Televantos serves as co-head of the specialty industrial practice. During his tenure, he has been part of more than 100 acquisitions and successful exits in the chemicals and materials sectors and has co-led the team that made Arsenal Capital the leading investor in chemicals and materials businesses. In addition to serving on the Boards of several Arsenal- owned companies, he is Lead Director of the Board of Balchem Corp (BCPC).

John holds BS and PhD degrees in chemical engineering from the University of London, Imperial College.

  ©  Copyright 1996-2021. Capital Link, Inc. All rights reserved.

visit:  |  |  |  |

Disclaimer & Terms Of Use. The information herein is not an offer to buy or sell any kind of securities nor does it constitute investment advice of any kind. Capital Link does not represent or warrant the accuracy of the information in this site. The user of the site acknowledges that he/she accesses the information at his/her own risk and cannot hold Capital Link liable for any matter in any way. Please read full disclaimer and terms of use.